CB Insights
Technology Market Intelligence
Technology Market Intelligence
ACADIA Pharmaceuticals, formerly Recptor Technologies, is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. The company has five drug...Show all
Company (IPO / Went public)
Phone: 858-558-2871
3911 Sorrento Valley Boulevard
San Diego, 92121
California, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| ACADIA Pharmaceuticals | $47.7M | Apr 6, 2005 |
| Alexza Pharmaceuticals | $163.4M | May 10, 2016 |
| Agios Pharmaceuticals | $376.3M | Jul 24, 2013 |
| See all 5 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Methods of treatment using selective 5-ht2a inverse agonists | Mar 21, 2011 | Sep 19, 2017 | Patent |
| Methods for the treatment of parkinson's disease psychosis using pimavanserin | Aug 24, 2016 | Sep 12, 2017 | Patent |
| Muscarinic agonists | Mar 14, 2014 | Jun 06, 2017 | Patent |
| Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases | Nov 06, 2015 | Feb 14, 2017 | Patent |
| Tetrahydroquinoline analogues as muscarinic agonists | Feb 05, 2014 | Dec 20, 2016 | Patent |
